About Dyadic International (OTCMKTS:DYAI)
Dyadic International, Inc., a biotechnology company, engages in the discovery, development, production, and sale of enzymes and other proteins in the United States and the Netherlands. It utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial production of human and animal vaccines, monoclonal antibodies, biosimilars and/or biobetters, and other therapeutic proteins. Dyadic International, Inc. has a research collaboration with Mitsubishi Tanabe Pharma Corporation to explore the potential of its C1 technology to produce two vital therapeutic proteins for human health indications. The company was founded in 1979 and is headquartered in Jupiter, Florida.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:DYAI
CUSIPN/A
Phone561-743-8333
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$760,000.00
Price / Sales61.20
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-2,140,000.00
Net Margins-281.55%
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares31,010,000
Dyadic International (OTCMKTS:DYAI) Frequently Asked Questions
What is Dyadic International's stock symbol?
Dyadic International trades on the OTCMKTS under the ticker symbol "DYAI."
How were Dyadic International's earnings last quarter?
Dyadic International, Inc. (OTCMKTS:DYAI) announced its quarterly earnings results on Tuesday, March, 27th. The biotechnology company reported ($0.04) earnings per share for the quarter. The biotechnology company had revenue of $0.16 million for the quarter. View Dyadic International's Earnings History.
When is Dyadic International's next earnings date?
Who are some of Dyadic International's key competitors?
Some companies that are related to Dyadic International include Anavex Life Sciences (AVXL), HedgePath Pharmaceuticals (HPPI), Luna Innovations (LUNA), Senomyx (SNMX), Vitality Biopharma (VBIO), Cleveland BioLabs (CBLI), BIOQUAL (BIOQ), U.S. Stem Cell (USRM), Protalex (PRTX), Bioanalytical Systems (BASI), Oxygen Biotherapeutics (TENX), GeoVax (GOVX), Algae.tec (ALGXY) and Redpoint Bio (RPBC).
Who are Dyadic International's key executives?
Dyadic International's management team includes the folowing people:
- Mr. Mark A. Emalfarb, Founder, Chief Exec. Officer, Pres and Director (Age 62)
- Mr. Thomas L. Dubinski CPA, Chief Financial Officer, VP and Corp. Sec. (Age 61)
- Mr. Matthew S. Jones, Managing Director of Bus. Devel. & Licensing
- Dr. Ronen Tchelet Ph.D., VP of Research & Bus. Devel.. (Age 60)
Has Dyadic International been receiving favorable news coverage?
Media headlines about DYAI stock have been trending positive on Thursday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dyadic International earned a daily sentiment score of 0.27 on Accern's scale. They also assigned headlines about the biotechnology company an impact score of 46.74 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Dyadic International?
Shares of DYAI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Dyadic International's stock price today?
One share of DYAI stock can currently be purchased for approximately $1.50.
How big of a company is Dyadic International?
Dyadic International has a market capitalization of $47.44 million and generates $760,000.00 in revenue each year.
How can I contact Dyadic International?
Dyadic International's mailing address is 140 Intracoastal Pointe Drive Suite 404, Jupiter FL, 33477-5094. The biotechnology company can be reached via phone at 561-743-8333 or via email at [email protected]
MarketBeat Community Rating for Dyadic International (DYAI)
MarketBeat's community ratings are surveys of what our community members think about Dyadic International and other stocks. Vote "Outperform" if you believe DYAI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DYAI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Dyadic International (OTCMKTS:DYAI) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 4/26/2016 forward)
Dyadic International (OTCMKTS:DYAI) Earnings History and Estimates Chart
Dyadic International (OTCMKTS DYAI) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/10/2018 | | | | | | | N/A |  |
| 3/27/2018 | Q4 2017 | | ($0.04) | | $0.16 million | View | N/A | |
| 11/9/2017 | Q3 2017 | | ($0.05) | | $0.27 million | View | N/A | |
| 8/10/2017 | Q2 2017 | | ($0.05) | | $0.21 million | View | N/A | |
| 5/11/2017 | Q1 2017 | | ($0.03) | | $0.12 million | View | N/A | |
| 3/15/2017 | Q4 2016 | | ($0.06) | | $0.49 million | View | N/A | |
| 11/10/2016 | Q3 2016 | | ($0.03) | | | View | N/A | |
| 8/11/2016 | Q2 | | $0.01 | | $0.02 million | View | Listen | |
| 5/12/2016 | Q1 | | ($0.02) | | $0.09 million | View | Listen | |
| 11/12/2015 | Q3 2015 | | $0.04 | | $0.21 million | View | N/A | |
| 8/14/2015 | Q2 2015 | | ($0.01) | | $3.83 million | View | N/A | |
| 5/14/2015 | Q1 2015 | | ($0.01) | | $4.03 million | View | N/A | |
| 3/11/2015 | Q4 2014 | | ($0.05) | | $2.69 million | View | N/A | |
| 11/13/2014 | Q3 2014 | | ($0.03) | | $3.79 million | View | N/A | |
| 8/14/2014 | Q2 2014 | | ($0.05) | | $3.06 million | View | N/A | |
| 5/8/2014 | Q1 2014 | | ($0.02) | | $2.99 million | View | N/A | |
| 3/13/2014 | Q4 2013 | | ($0.01) | | $4.11 million | View | N/A | |
| 11/14/2013 | Q3 2013 | | ($0.05) | | $3.46 million | View | N/A | |
| 8/8/2013 | Q2 2013 | | $0.10 | | $7.08 million | View | N/A | |
| 5/15/2013 | Q1 2013 | | ($0.05) | | $2.48 million | View | N/A | |
| 3/7/2013 | Q4 2012 | | ($0.04) | | | View | N/A | |
| 11/8/2012 | Q3 2012 | | ($0.03) | | | View | N/A | |
| 8/13/2012 | Q2 2012 | | $0.12 | | | View | N/A | |
| 5/10/2012 | Q1 2012 | | ($0.02) | | | View | N/A | |
| 3/27/2012 | Q4 2011 | | ($0.04) | | | View | N/A | |
| 11/3/2011 | Q3 2011 | | ($0.04) | | | View | N/A | |
| 8/4/2011 | Q2 2011 | | ($0.02) | | | View | N/A | |
| 5/5/2011 | Q1 2011 | | ($0.05) | | | View | N/A | |
| 3/10/2011 | Q4 2010 | | ($0.05) | | | View | N/A | |
| 11/15/2010 | Q3 2010 | | ($0.05) | | | View | N/A | |
| 8/13/2010 | Q2 2010 | | ($0.05) | | | View | N/A | |
| 5/14/2010 | Q1 2010 | | ($0.05) | | | View | N/A | |
| 3/25/2010 | Q4 2009 | | ($0.15) | | | View | N/A | |
| 11/16/2009 | Q3 2009 | | ($0.02) | | | View | N/A | |
| 10/26/2009 | Q1 2009 | | $0.07 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Dyadic International (OTCMKTS:DYAI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Dyadic International (OTCMKTS DYAI) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 0.21%
Dyadic International (OTCMKTS DYAI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Dyadic International (OTCMKTS DYAI) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018
finance.yahoo.com - April 25 at 4:58 PM |
| Dyadic International Announces 2017 Year End Results and Recent Developments
finance.yahoo.com - March 27 at 4:44 PM |
 | Dyadic International (DYAI) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - March 20 at 2:10 AM |
| Dyadic International Appoints Chief Accounting Officer
finance.yahoo.com - March 15 at 5:25 PM |
| VIDEO: Dyadic International Inc., President, Chief Executive Officer and Director Mark A. Emalfarb and Chief Commercial Officer Matthew Jones Featured in OTCQX Video Series
finance.yahoo.com - March 6 at 5:08 PM |
| The Story Behind Growth: New Report Discusses Harleysville Savings Financial and Dyadic International - Emerging Trends Within New Industry
finance.yahoo.com - March 5 at 9:03 AM |
| Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe Pharma Corporation To Produce Two Target Proteins in C1
finance.yahoo.com - February 27 at 9:01 AM |
| Dyadic International, Inc. Announces Research and Development Collaboration To Produce An Active Ingredient in C1
finance.yahoo.com - February 7 at 9:35 AM |
| Dyadic International, Inc. Announces Research and Development Collaboration with the Israel Institute for Biological Research (IIBR) to Combat Emerging Diseases & Threats
finance.yahoo.com - January 16 at 9:53 AM |
 | Dyadic International's (DYAI) CEO Mark Emalfarb on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 4:43 AM |
| Dyadic International Inc. (DYAI) Releases Earnings Results
www.americanbankingnews.com - November 11 at 10:38 AM |
| Dyadic International, Inc. to Host Earnings Call
finance.yahoo.com - November 10 at 11:40 AM |
| Dyadic International to Announce Third Quarter 2017 Financial Results and Host Conference Call on Thursday November 9, 2017
finance.yahoo.com - November 7 at 5:35 AM |
| Dyadic International Inc. (DYAI) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - November 2 at 3:50 AM |
| Dyadic International to Announce Third Quarter 2017 Financial Results and Host Conference Call on Thursday November 9, 2017
finance.yahoo.com - October 26 at 6:49 PM |
| Dyadic International Presentation Now Available for On-Demand Viewing
finance.yahoo.com - October 9 at 6:27 PM |
 | Dyadic International to Webcast, Live, at VirtualInvestorConferences.com October 5
www.prnewswire.com - September 30 at 3:57 PM |
| Dyadic International, Inc. :DYAI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 7:38 PM |
| Dyadic Announces $5 Million Stock Repurchase Program
finance.yahoo.com - August 16 at 6:28 PM |
| Dyadic International's (DYAI) CEO Mark Emalfarb on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 5:24 AM |
| Dyadic International Inc. (OTCMKTS:DYAI) Posts Earnings Results
www.americanbankingnews.com - August 10 at 8:52 PM |
| Dyadic International Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 10 at 7:20 PM |
 | BRIEF-Dyadic concludes research services agreement with Dupont
www.reuters.com - August 4 at 6:18 PM |
| Dyadic Announces the Conclusion of Its Research Services Agreement With DuPont
finance.yahoo.com - August 4 at 6:18 PM |
| Dyadic International Inc. (DYAI) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - August 3 at 10:40 AM |
| Dyadic International to Announce Second Quarter 2017 Financial Results and Host Conference Call on Thursday August 10, 2017
finance.yahoo.com - July 27 at 6:36 PM |
| Dyadic Announces an Important Multi-Year Research and Development Arrangement to Further Advance Its Proprietary C1 Technology
finance.yahoo.com - July 10 at 5:58 PM |
| Dyadic International's (DYAI) CEO Mark Emalfarb on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 5:21 PM |
| Q4 2016 Dyadic International Inc Earnings Release - After Market Close
biz.yahoo.com - March 15 at 5:15 PM |
 | Jupiter biotech firm inks seven-figure settlement with Greenberg Traurig
www.bizjournals.com - March 3 at 9:54 PM |
 | Dyadic International Announces It Has Reached a Settlement With the Last Remaining Defendant Law Firm, Greenberg Traurig, LLP and Greenberg Traurig, P.A., in Its Professional Liability Litigation
us.rd.yahoo.com - March 3 at 4:53 PM |
| 4:34 pm Dyadic International purchased 2.36 mln shares of common stock from Pinnacle Family Office Investments
us.rd.yahoo.com - January 14 at 4:08 AM |
| Dyadic International's (DYAI) CEO Mark Emalfarb on Q3 2016 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 11:50 AM |
| Q3 2016 Dyadic International Inc Earnings Release - After Market Close
biz.yahoo.com - November 10 at 1:24 PM |
 | Form SC 13G/A DYADIC INTERNATIONAL Filed by: KITT BARRY M
www.streetinsider.com - October 28 at 4:30 PM |
| Q2 2016 Dyadic International Inc Earnings Release - After Market Close
biz.yahoo.com - August 11 at 7:49 AM |
| Dyadic (DYAI), Sanofi Pasteur Terminate Agreement
www.streetinsider.com - August 9 at 7:58 AM |
Dyadic International (OTCMKTS:DYAI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Dyadic International (OTCMKTS DYAI) Stock Chart for Thursday, April, 26, 2018
Loading chart…
